Search results
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 3 days agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...
Ryvu Therapeutics to present clinical and preclinical data on RVU120 at the 2024 European Hematology...
FOX 23 News Albany· 2 days agoUpdated data from the Phase I trial of RVU120 in patients with relapsed/refractory acute myeloid...
Rising Stars: Europe's Best Up-and-Coming Female Lawyers, 2024 | Law.com International
Law.com· 2 days agoWomen working in the commercial legal industry across Continental Europe have continued to grow and...
AstraZeneca pulls its COVID-19 vaccine from European market after history of stumbles
Fortune· 7 days agoIn an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization ...
Q1 2024 Matinas BioPharma Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoWhile we work to secure MAT2203 future. We are grateful to our new investors for their support. Keith? Keith Kucinski Thank you, Jerry, and good afternoon. In reviewing our financial performance ...
Vicore Expands and Strengthens its Board of Directors
Digital Journal· 2 days ago...Corporate Development at Kronos Bio (Nasdaq: KRON), Chief Financial and Strategy Officer at Neon Therapeutics (Nasdaq: NTGN), acquired by BioNTech, and Chief Financial Officer and Head of Corporate Development at Merrimack Pharmaceuticals (Nasdaq: MACK), leading its 1 billion USD asset sale to...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
AOL· 5 days agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for Novavax's COVID-19 vaccine and take ...